Gillibrand seeks to cap out-of-pocket drug costs

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x

Gillibrand aims to lower drug costs

Gillibrand aims to lower drug costs with legislation.

U.S. Sen. Kirsten Gillibrand is proposing legislation to reduce the cost of prescription drugs.

The Capping Prescription Costs Act legislation would cap the annual out-of-pocket cost of prescription drugs at $2,000 for individuals and $4,000 for families with private insurance.

Gillibrand said in a virtual news conference on Wednesday that her office heard last month from a New Yorker named Kim with a chronic health condition. She says her doctor prescribed a medication that has helped her tremendously. Sadly, her health insurance doesn’t cover it, and it cost $1,000 a month. Her doctor tried to prescribe her a cheaper medication, but the cost for that drug was still prohibitive at about $800 a month.

“My office has heard from tens of thousands of New Yorkers like Kim who have urged me to help cut the cost of prescription drugs,” Gillibrand said.

Gillibrand helped to pass the Inflation Reduction Act in 2022, which capped Medicare patients’ out-of-pocket expenses and costs and regulated the price increases by drug companies.